NASDAQ:OPGN
OpGen, Inc. Stock News
$0.535
+0.0201 (+3.90%)
At Close: Apr 29, 2024
OpGen Group Company Ares Genetics Presents R&D Pipeline Updates
07:30am, Monday, 28'th Jun 2021
ROCKVILLE, Md., June 28, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat inf
5 Top Penny Stocks Insiders Decided To Buy In June 2021
11:55am, Tuesday, 15'th Jun 2021
Penny stocks to watch right now after insiders bought in June. The post 5 Top Penny Stocks Insiders Decided To Buy In June 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Pen
OPGN Stock Price Increases Over 20% Pre-Market: Why It Happened
05:10am, Tuesday, 15'th Jun 2021
The stock price of OpGen Inc (NASDAQ: OPGN) increased by over 20% pre-market. This is why it happened.
OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed
04:30pm, Wednesday, 09'th Jun 2021
ROCKVILLE, Md., June 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the “Company”), a precision medicine company harnessing the power of molecular diagnostics and informati
OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webinars
07:30am, Wednesday, 09'th Jun 2021
ROCKVILLE, Md., June 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat inf
OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move to New Headquarters in Maryland
07:30am, Monday, 07'th Jun 2021
ROCKVILLE, Md., June 07, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat inf
OpGen, Inc. (OPGN) CEO Oliver Schacht on Q1 2021 Results - Earnings Call Transcript
02:41pm, Thursday, 13'th May 2021
OpGen, Inc. (OPGN) CEO Oliver Schacht on Q1 2021 Results - Earnings Call Transcript
OpGen, Inc. (OPGN) Reports Q1 Loss, Misses Revenue Estimates
12:55pm, Thursday, 13'th May 2021
OpGen, Inc. (OPGN) delivered earnings and revenue surprises of -31.82% and -50.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: OpGen Q1 Earnings
07:42am, Thursday, 13'th May 2021
Shares of OpGen (NASDAQ:OPGN) moved higher by 1.3% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 16.28% year over year to ($0.50), which missed
OpGen Reports First Quarter 2021 Financial Results and Provides Business Update
07:30am, Thursday, 13'th May 2021
Conference call to be held at 8:30 a.m. Eastern Time today
OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time
07:30am, Thursday, 29'th Apr 2021
GAITHERSBURG, Md., April 29, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its first
OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections
07:30am, Monday, 19'th Apr 2021
GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that its strategic collaboration with the New York State Department of Health (“DOH”) to develo
OpGen, Inc. (OPGN) Reports Q4 Loss, Tops Revenue Estimates (Revised)
04:33am, Friday, 26'th Mar 2021
OpGen, Inc. (OPGN) delivered earnings and revenue surprises of -20.69% and 4.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
OpGen's (OPGN) CEO Oliver Schacht on Q4 2020 Results - Earnings Call Transcript
11:08pm, Thursday, 25'th Mar 2021
OpGen's (OPGN) CEO Oliver Schacht on Q4 2020 Results - Earnings Call Transcript
OpGen, Inc. (OPGN) Reports Q4 Loss, Tops Revenue Estimates
06:11pm, Thursday, 25'th Mar 2021
OpGen, Inc. (OPGN) delivered earnings and revenue surprises of -6.90% and 4.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?